Fate Therapeutics, Inc. (FRA:F6T)

Fate Therapeutics Statistics

Total Valuation

FRA:F6T has a market cap or net worth of EUR 102.20 million. The enterprise value is -14.93 million.

Market Cap	102.20M
Enterprise Value	-14.93M

Important Dates

The last earnings date was Thursday, November 20, 2025.

Earnings Date	Nov 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	115.35M
Shares Outstanding	n/a
Shares Change (YoY)	+8.77%
Shares Change (QoQ)	+0.40%
Owned by Insiders (%)	1.44%
Owned by Institutions (%)	63.41%
Float	100.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	16.80
PB Ratio	0.51
P/TBV Ratio	0.51
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	0.11
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.15

Financial Position

The company has a current ratio of 7.87, with a Debt / Equity ratio of 0.34.

Current Ratio	7.87
Quick Ratio	7.74
Debt / Equity	0.34
Debt / EBITDA	n/a
Debt / FCF	-0.69
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -52.35% and return on invested capital (ROIC) is -25.82%.

Return on Equity (ROE)	-52.35%
Return on Assets (ROA)	-23.85%
Return on Invested Capital (ROIC)	-25.82%
Return on Capital Employed (ROCE)	-50.70%
Revenue Per Employee	33,607
Profits Per Employee	-735,022
Employee Count	181
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -63.77% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-63.77%
50-Day Moving Average	1.03
200-Day Moving Average	0.98
Relative Strength Index (RSI)	46.76
Average Volume (20 Days)	480

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.55

Income Statement

In the last 12 months, FRA:F6T had revenue of EUR 6.08 million and -133.04 million in losses. Loss per share was -1.12.

Revenue	6.08M
Gross Profit	-78.76M
Operating Income	-136.36M
Pretax Income	-133.04M
Net Income	-133.04M
EBITDA	-123.88M
EBIT	-136.36M
Loss Per Share	-1.12

Balance Sheet

The company has 183.61 million in cash and 67.54 million in debt, giving a net cash position of 116.06 million.

Cash & Cash Equivalents	183.61M
Total Debt	67.54M
Net Cash	116.06M
Net Cash Per Share	n/a
Equity (Book Value)	199.49M
Book Value Per Share	1.73
Working Capital	164.61M

Cash Flow

In the last 12 months, operating cash flow was -94.24 million and capital expenditures -4.14 million, giving a free cash flow of -98.38 million.

Operating Cash Flow	-94.24M
Capital Expenditures	-4.14M
Free Cash Flow	-98.38M
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	-2,241.75%
Pretax Margin	-2,187.11%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:F6T does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.77%
Shareholder Yield	-8.77%
Earnings Yield	-130.17%
FCF Yield	-96.26%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:F6T has an Altman Z-Score of -6.02 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.02
Piotroski F-Score	1